IndraLab

Statements


| 7

reach
"The 45 kD or 20 kD caspase-1 was increased by I/R or CsA, respectively, and decreased by rapamycin (P < 0.05)."

reach
"Similarly, rapamycin, a selective mTORC1 inhibitor (Benjamin et al., 2011), suppressed caspase-1 activation in wild-type BMDMs in response to LPS and ATP, compared to vehicle control."

reach
"Caspase-1 remained activated in GMs after treatment with rapamycin, although to a lesser extent than with LPS and ATP, while rapamycin inhibited caspase-1 activation in control macrophages."

reach
"Rapamycin treatment significantly suppressed IL-1beta secretion and caspase-1 cleavage in a dose dependent manner."

reach
"Rapamycin effectively downregulated the mRNA expression levels of tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), toll-like receptor 4 (TLR4), nucleotide binding oligomerization domain-like receptors (NLR) family pyrin domain-containing 3 (NLRP3), and Caspase-1, and suppressed the infiltration of neutrophils and macrophages."

reach
"Similarly, rapamycin, a selective mTORC1 inhibitor, suppressed caspase-1 activation in wild type BMDM in response to LPS and ATP, compared to vehicle control (XREF_FIG)."

reach
"In contrast to the finding with 3-MA, rapamycin inhibited PrP106-126-induced activation of caspase-1 (p45), and microglial cells produced decreased level of caspase-1 p10."